Trial record 1 of 1 for:
NCT05238324
Safety and Efficacy of HMI-203 in ERT-Treated Adults With MPS II
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05238324 |
|
Recruitment Status :
Withdrawn
(Homology Medicines has discontinued development of this program.)
First Posted : February 14, 2022
Last Update Posted : August 28, 2023
|
Sponsor:
Homology Medicines, Inc
Information provided by (Responsible Party):
Homology Medicines, Inc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Estimated Primary Completion Date : | October 2024 |
| Estimated Study Completion Date : | January 2029 |